ACA vs KBR
Arcosa, Inc. vs KBR, Inc. — AI-powered side-by-side comparison
| Metric | ACA | KBR |
|---|
| AI Score |
65
|
70
|
| Price |
$144.97
|
$37.58
|
| P/E Ratio |
14.49×
|
11.31×
|
| ROE |
7.9%
|
27.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
23.0%
|
14.5%
|
| Debt / Equity |
0.48×
|
1.71×
|
| Dividend Yield |
0.1%
|
1.8%
|
| RSI (14) |
51.0
|
62.8
|
| Beta |
1.071
|
0.445
|
| Expected Upside |
—
|
+3.2%
|
AI Committee View
Current Innellis committee reasoning for ACA versus KBR.
KBR leads by 5 points.
KBR scores 70/100 (Buy) versus ACA at 65/100 (Buy).
ACA Committee View
83% agreement
6 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is news sentiment is negative (-0.33 across 3 articles, 14d). The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 14.5 is inexpensive for the broad market — Value
- ROE of 18.1% shows genuine earnings power backing the valuation — Value
- EPS growing 431.7% YoY — Growth
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- News sentiment is negative (-0.33 across 3 articles, 14d) — News
KBR Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.